Danaher Schedules Fourth Quarter 2025 Earnings Conference Call
Danaher (NYSE: DHR) will webcast its Fourth Quarter 2025 earnings conference call on Wednesday, January 28, 2026 at 8:00 a.m. ET, with an expected duration of about one hour.
Rhea-AI Summary
Danaher (NYSE: DHR) will webcast its Fourth Quarter 2025 earnings conference call on Wednesday, January 28, 2026 at 8:00 a.m. ET, with an expected duration of about one hour.
The company will discuss financial performance and future expectations. The live webcast and accompanying slide presentation will be available in the Investors > Events & Presentations section at www.danaher.com. Webcast slides, the earnings press release, and related materials will be posted beginning at 6:00 a.m. ET on the day of the call.
Dial-in access: 800-245-3047 (U.S.) or +1 203-518-9765 (outside U.S.); Conference ID: DHRQ425. A replay of the webcast and call will be available after the presentation; the call replay remains available until February 11, 2026.
Positive
- None.
Negative
- None.
Details
News Market Reaction – DHR
In the Dec 17 session, DHR declined 0.92%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Current price
- $224.70
- Prior to Q4 2025 call scheduling announcement
- 52-week range
- $171.00 – $258.23
- Stock trades 12.98% below 52-week high, 31.4% above low
- Market cap
- $161,422,065,632
- Equity value before Q4 2025 earnings call update
- Call date & time
- Jan 28, 2026, 8:00 a.m. ET
- Q4 2025 earnings conference call schedule
- Call duration
- Approximately 1 hour
- Planned length of Q4 2025 earnings call
- Replay availability
- Until Feb 11, 2026
- Telephone/webcast replay of Q4 2025 call
- US dial-in
- 800-245-3047
- Domestic access number for Q4 2025 earnings call
- Intl dial-in
- +1 203-518-9765
- International access number for Q4 2025 earnings call
Historical Context
-
Announced regular cash dividend of $0.32 per share with set pay date.
-
CEO presentation at Jefferies healthcare conference with live webcast access.
-
Q3 2025 results with revenue, EPS growth and maintained full-year guidance.
-
Scheduled Q3 2025 earnings call with webcast and replay details.
-
Launch of automated BD-Tau RUO immunoassay advancing neurodegenerative research.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.
You can access the conference call by dialing 800-245-3047, within the
Danaher's earnings press release, the webcast slides and other related materials will be posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings" beginning at 6:00 a.m. ET on the date of the earnings call and will remain available following the call.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-schedules-fourth-quarter-2025-earnings-conference-call-302644315.html
SOURCE Danaher Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.